Illustrative scenario: A child with a central line is now afebrile and hemodynamically stable, but the initial blood culture later grows coagulase-negative staphylococcus (CoNS). The wrong reflex is either “contaminant—ignore it” or “CLABSI—pull the line and give 14 days.” The useful question is narrower: Is this a true catheter-related bloodstream infection, and if so, can the line be safely salvaged?
In a child with sepsis or hemodynamic instability, obtain cultures promptly but do not delay empiric therapy or necessary source control while waiting for a perfect diagnostic set.
The first decision is not “remove or retain”
CoNS occupies both sides of the diagnostic divide. It is a frequent skin contaminant and also a common cause of catheter-related infection because it adheres to intravascular plastic and forms biofilm.
A single positive CoNS bottle or blood-culture set should therefore trigger confirmation when the child is clinically stable. Obtain paired cultures drawn simultaneously from the suspected catheter and a peripheral vein before new antibiotics or catheter removal when feasible, and label the source of each specimen. Differential time to positivity is most interpretable when the cultures are collected at the same time with comparable, adequate blood volumes. With a multilumen catheter, sampling additional lumens may help, but adequate blood volume is more important than drawing so many cultures that each specimen becomes low volume.
| Culture pattern | What it suggests | Immediate reasoning |
|---|---|---|
| One positive CoNS bottle or set without corroborating cultures | Contamination remains possible | If the child is stable, repeat appropriately collected paired cultures rather than committing immediately to line removal or a prolonged course |
| The same CoNS from catheter and peripheral cultures, or catheter positivity at least 2 hours earlier than a simultaneous, adequately filled peripheral culture | True catheter-related infection is more likely | Begin or continue targeted systemic therapy and obtain follow-up cultures to document clearance |
| Repeated catheter-drawn cultures positive while peripheral cultures remain negative | Intraluminal catheter colonization is possible without established bloodstream infection | Seek pediatric infectious diseases or antimicrobial-stewardship input; a lock-based strategy may be considered if the line must remain, but this pattern is not automatically confirmed CRBSI |
Remember the terminology: CLABSI is primarily a surveillance term for a primary bloodstream infection associated with a central line; it does not by itself prove that the line caused the infection. CRBSI is a clinical diagnosis supported by microbiologic evidence that identifies the catheter as the source. That distinction matters because catheter removal and antibiotic-lock therapy are source-control decisions. A child’s improvement after antibiotics does not by itself prove that the line was or was not the source.
Retention is a conditional strategy, not a default
Catheter salvage is most defensible when the line is genuinely important—such as an essential tunneled catheter or port used for parenteral nutrition, chemotherapy, dialysis, or prolonged treatment—and the infection is uncomplicated. The usual salvage profile includes:
- No exit-site, tunnel, or port-pocket infection.
- No severe sepsis or hemodynamic instability.
- No evidence of endocarditis, suppurative thrombophlebitis, or metastatic infection.
- A routine CoNS species with the expected relatively indolent behavior, rather than Staphylococcus lugdunensis.
- Blood-culture clearance promptly after appropriate active therapy, generally within 72 hours of treatment initiation.
The value of pediatric venous access matters. Removing a line can consume future access sites, require anesthesia or a new procedure, and create major problems for a child with intestinal failure or malignancy. But a valuable line is not a reason to ignore microbiologic failure.
Remove the catheter when the infection is complicated, the line is no longer needed, or bacteremia persists despite appropriate therapy. Persistence at 72 hours after initiation of active therapy should prompt catheter removal when feasible and evaluation for an infected thrombus, endocarditis, an occult metastatic focus, or an incorrect antimicrobial choice. Relapse with the same organism after treatment raises concern for unresolved catheter infection or another source and should trigger renewed source-control assessment.
A key laboratory exception is S. lugdunensis. Although it is coagulase-negative by laboratory classification, it can behave more like S. aureus, including causing invasive and metastatic disease. Do not place it automatically into the routine CoNS salvage pathway.
Why a retained line needs a biofilm plan
Systemic therapy may sterilize the bloodstream without reliably eradicating organisms embedded on the catheter’s inner surface. For an uncomplicated infection involving a retained long-term catheter, the classic treatment framework combines systemic antibiotics with an antibiotic lock directed into the catheter lumen.
Pediatric evidence for lock therapy is limited and heterogeneous. The appropriate agent, concentration, dwell time, anticoagulant compatibility, and safety considerations vary by catheter type, age, organism, and institutional pharmacy practice. The practical lesson is not to prescribe a lock recipe from memory. Instead, involve pediatric infectious diseases, pharmacy, and the local line-infection protocol. A lock cannot substitute for catheter removal when there is tunnel infection, pocket infection, infected thrombus, or persistent bacteremia.
When empiric gram-positive therapy is indicated and methicillin resistance is a concern, vancomycin is commonly used; the overall empiric regimen must still reflect illness severity, local susceptibility data, and the child’s risk for gram-negative or fungal infection. Once the isolate is characterized, narrow therapy when a susceptible beta-lactam such as oxacillin or cefazolin, or another appropriate agent, is available. Prolonged vancomycin is not a goal in itself.
Count treatment from clearance, not from the first fever
For a confirmed, uncomplicated CoNS CRBSI, the commonly used duration framework is:
| Catheter plan | Typical duration | How to count it |
|---|---|---|
| Catheter removed and cultures clear promptly | 5–7 days of active therapy | Count day 1 from the first negative blood culture documenting clearance |
| Long-term catheter retained for salvage | 10–14 days of systemic therapy, with adjunctive lock therapy | Count day 1 from the first negative blood culture; continue follow-up for relapse or recurrent bacteremia |
| Persistent or complicated infection | Longer, site-specific therapy | Endocarditis, suppurative thrombophlebitis, osteomyelitis, or another metastatic focus determines duration |
For these duration frameworks, the treatment clock begins with documented bloodstream clearance rather than resolution of fever. Obtain follow-up cultures until clearance is documented, particularly when the line is being retained. “The child is afebrile” is not the same as “the bloodstream is clear.”
Some guidance permits observation without antibiotics after catheter removal in highly selected patients who have no intravascular or orthopedic hardware and have negative follow-up cultures obtained after removal while not receiving antibiotics. This is a low-evidence exception, not a routine shortcut for an immunocompromised child, an uncertain diagnosis, or incomplete culture follow-up.
Common traps worth correcting
- “CoNS is a contaminant.” Sometimes—but it is also a major catheter pathogen. The number, timing, source, and concordance of positive cultures matter.
- “A central line plus bacteremia proves CRBSI.” No. CLABSI surveillance association and clinical CRBSI causation are not interchangeable.
- “Afebrile means cured.” Clinical improvement is reassuring; it does not replace clearance cultures.
- “Every CoNS episode gets 10–14 days.” That duration fits many retained-line cases, not every culture-positive episode. Removal with prompt clearance may permit 5–7 days.
- “Retain the line and give vancomycin.” Salvage should include a deliberate plan for biofilm, monitoring, and failure criteria, with de-escalation when susceptibility results permit.
- “All coagulase-negative staphylococci are low risk.” S. lugdunensis is the important exception.
A board-ready synthesis is: confirm that CoNS represents true catheter-related infection; if the child is stable, the line is essential, there is no tunnel or metastatic infection, and cultures clear within 72 hours of appropriate therapy, salvage may be attempted with targeted systemic therapy and a locally approved lock strategy. Treat for 10–14 days from the first negative culture. Remove the line for persistent bacteremia or complications; if an uncomplicated line is removed and cultures clear promptly, 5–7 days is usually sufficient.
Practical takeaways
- CoNS requires source confirmation, not automatic dismissal or automatic catheter removal.
- CLABSI surveillance association does not by itself establish clinical CRBSI; paired catheter and peripheral cultures help identify the source.
- Retain only an essential long-term line in an uncomplicated infection with documented clearance and a defined lock-and-monitoring plan.
- Persistent bacteremia at 72 hours after appropriate therapy is a salvage-failure signal and should trigger catheter removal and complication evaluation.
- Antibiotic duration follows catheter management and culture clearance: typically 5–7 days after removal versus 10–14 days with retained-line salvage.